3 Growth Companies With High Insider Ownership Seeing 21% Earnings Growth

As global markets navigate a mixed landscape marked by fluctuating consumer confidence and economic data, major U.S. stock indexes have shown moderate gains, particularly driven by large-cap growth stocks. In this environment, companies with high insider ownership can be appealing to investors seeking alignment of interests between management and shareholders, especially when these companies are demonstrating strong earnings growth.

Top 10 Growth Companies With High Insider Ownership

Name	Insider Ownership	Earnings Growth
Arctech Solar Holding (SHSE:688408)	37.9%	25.6%
Duc Giang Chemicals Group (HOSE:DGC)	31.4%	23.8%
Seojin SystemLtd (KOSDAQ:A178320)	30.9%	39.9%
People & Technology (KOSDAQ:A137400)	16.4%	37.3%
SKS Technologies Group (ASX:SKS)	29.7%	24.8%
Medley (TSE:4480)	34%	31.7%
Pharma Mar (BME:PHM)	11.8%	56.2%
Fine M-TecLTD (KOSDAQ:A441270)	17.2%	131.1%
Fulin Precision (SZSE:300432)	13.6%	66.7%
HANA Micron (KOSDAQ:A067310)	18.5%	110.9%

Click here to see the full list of 1501 stocks from our Fast Growing Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Xiamen Yan Palace Bird's Nest Industry (SEHK:1497)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Xiamen Yan Palace Bird's Nest Industry Co., Ltd. focuses on the research, development, production, and marketing of edible bird’s nest products in China and has a market cap of HK$3.72 billion.

Operations: The company's revenue segments include CN¥21.07 million from sales to online distributors, CN¥508.94 million from sales to offline distributors, CN¥907.52 million from direct sales to online customers, CN¥344.32 million from direct sales to offline customers, and CN¥290.51 million from direct sales to e-commerce platforms.

Insider Ownership: 26.7%

Earnings Growth Forecast: 31.5% p.a.

Xiamen Yan Palace Bird's Nest Industry is poised for significant growth, with earnings projected to increase 31.48% annually, outpacing the Hong Kong market's 11.1%. Revenue is expected to grow at 13.1% per year, surpassing the market average of 7.6%, although it remains below the high-growth threshold of 20%. Despite no recent insider trading activity, its forecasted return on equity of 24.2% in three years highlights strong potential profitability and efficient capital use.

• Take a closer look at Xiamen Yan Palace Bird's Nest Industry's potential here in our earnings growth report.
• Insights from our recent valuation report point to the potential overvaluation of Xiamen Yan Palace Bird's Nest Industry shares in the market.

Changzhou Tenglong AutoPartsCo.Ltd (SHSE:603158)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Changzhou Tenglong AutoPartsCo., Ltd. is engaged in the research, development, manufacturing, and sale of auto parts both in China and internationally, with a market cap of CN¥3.92 billion.

Operations: Changzhou Tenglong AutoPartsCo., Ltd. generates revenue through the research, development, manufacturing, and sale of auto parts in both domestic and international markets.

Insider Ownership: 16.7%

Earnings Growth Forecast: 21.1% p.a.

Changzhou Tenglong AutoPartsCo.Ltd. is positioned for growth with revenue expected to rise 27.7% annually, surpassing the Chinese market's 13.7%. Despite a forecasted earnings growth of 21.1% per year, which trails the market's 25.4%, its price-to-earnings ratio of 13.5x suggests good value relative to peers and industry norms. Recent earnings reports show substantial improvement, with net income increasing from CNY 140.39 million to CNY 236.43 million over nine months in 2024.

• Click to explore a detailed breakdown of our findings in Changzhou Tenglong AutoPartsCo.Ltd's earnings growth report.
• According our valuation report, there's an indication that Changzhou Tenglong AutoPartsCo.Ltd's share price might be on the cheaper side.

Stratec (XTRA:SBS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Stratec SE, along with its subsidiaries, designs and manufactures automation and instrumentation solutions for in-vitro diagnostics and life sciences globally, with a market cap of €362.25 million.

Operations: The company's revenue is primarily derived from its Automation Solutions for Highly Regulated Laboratory segment, which generated €250.54 million.

Insider Ownership: 30.9%

Earnings Growth Forecast: 25.4% p.a.

Stratec faces challenges with recent earnings showing a decline, as third-quarter sales fell to €57.23 million from €62.67 million year-on-year, and net income dropped significantly. Despite this, the company is trading below its estimated fair value and analysts expect a 37.6% stock price increase. Forecasts suggest significant annual earnings growth of 25.4%, outpacing the German market's 20.5%. However, high debt levels and share price volatility remain concerns for investors seeking stability.

• Get an in-depth perspective on Stratec's performance by reading our analyst estimates report here.
• The analysis detailed in our Stratec valuation report hints at an deflated share price compared to its estimated value.

Key Takeaways

• Embark on your investment journey to our 1501 Fast Growing Companies With High Insider Ownership selection here.
• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com